Below you'll find a list of all posts that have been tagged as “Archangels”
As dentists worldwide begin to tackle the backlog of patients whose tooth decay may have worsened during the Covid-19 pandemic*, Edinburgh-based dental technology company, Calcivis, is preparing for a US launch with a restructuring of its board and the successful completion of its latest funding round.
Investment includes record-breaking contribution from Archangels’ syndicate members The Edinburgh-based business investment group, Archangels, has led investment of £12.4m in innovative Scottish tech and life sciences companies in the first half of 2021 (H1 2020: £9.5m) Archangels’ H1 2021 deals data, released today (14th July 2021), reveals that Archangels itself invested £7.3m during the first six months of 2021, with co-investment …
Mike Rutterford has won the Lifetime Achievement Award at the UKBAA Angel Investment Awards. Mike is a serial entrepreneur with a 40-year career as a business angel and in property investment. Educated in Edinburgh, in his 20s he launched Stuart Wyse Ogilivie and over a ten-year period developed the estate agency into the biggest in Scotland – subsequently selling to …
Despite the challenges of the COVID-19 pandemic, Edinburgh-based business angel investment syndicate, Archangels, led investments of £16.3m in promising Scottish start-up and early stage companies in 2020, topping its 2019 total of £13.4m by 22%.
Backing to fund the further expansion of formulation and manufacturing capabilities underpinned by strategic senior appointments Innovative Scottish-based drug delivery company, Bio-Images Drug Delivery Limited (BDD), has positioned itself for rapid growth with a further round of investment in its GMP* manufacturing capabilities alongside strategic recruitment to the senior leadership team and the Board of Directors. The £1.2m investment, has …
An innovative new system that has the potential to revolutionise hearing tests globally has received financial backing from Scottish business angel investment syndicate, Archangels.
The Edinburgh-based business angel investment syndicate, Archangels, has led investment of £3.3 million in innovative Scottish companies during the Coronavirus lockdown.
MGB Biopharma, the Glasgow-based biopharmaceutical company developing a novel class of anti-infectives, today announces the successful conclusion of its Phase II clinical study into MGB-BP-3, for the treatment of Clostridium difficile Infection (CDI). The study confirms that the drug has the potential to become the new gold standard, first-line treatment for CDI. CDI is a serious and often life-threatening infection of the large intestine …
Mike Rutterford helped launch Archangel 28 years ago and, driven by its four pillars of wisdom, the business angel syndicate has delivered success stories, cash – and fun.
Archangels, the Edinburgh-based business angel investment syndicate – believed to be the oldest in the world – has led investment of £6.2 million in Scottish early stage companies in the first quarter of 2020. Four tech and life sciences businesses – Blackford Analysis; Fios Genomics; Optoscribe; and Speech Graphics – were the recipients of the additional investment. £2.6 million came …
Optoscribe Ltd, a world-leading supplier of 3D glass-based integrated photonics components, today announced that the company has closed its latest investment round. This funding round, which was led by Scottish business angel investment syndicate, Archangels, with participation from Maven Capital Partners, Par Equity and Scottish Investment Bank, will facilitate the continued expansion of the business and enable extended commercial engagement. …
Edinburgh, March 5th 2020 – CALCIVIS, a medical devices company focused on modernising the management of tooth decay and enabling preventive dentistry, announces receipt of an Approvable Letter for the Premarket Approval (PMA) of its CALCIVIS® Imaging System from the US Food and Drug Administration (FDA). CALCIVIS intends to introduce this novel product in the US in 2021 with the …
Spreng Thomson: Intelligent Creative Communications
Spreng Thomson is committed to Fair Work, by ensuring that our people have an effective voice, by investing in their development and by not using zero hours contracts.
+44(0)141 548 5191
[email protected]
The Herald Building,
155 Albion Street,
Glasgow G1 1RU, UK
© 2025 Spreng Thomson Limited.
Registered in Scotland No. 173454
